Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion type Assertion NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_head.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion description "[Gene set analysis was performed on gene expression data from three cohorts of 234, 170, and 175 patients with HER2-normal lymph node-negative breast cancer who received no systemic adjuvant therapy to identify gene sets associated prognosis and three additional cohorts of 198, 85, and 62 patients with HER2-normal stage I-III breast cancer who received preoperative chemotherapy to identify gene sets associated with pathological complete response to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_provenance.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion evidence source_evidence_literature NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_provenance.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion SIO_000772 21191116 NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_provenance.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion wasDerivedFrom befree-20150227 NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_provenance.
- NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_assertion wasGeneratedBy ECO_0000203 NP878156.RAzNIndryfIfLwE6tSCrTM8B62Px-C8_pcshImCJ47QtM130_provenance.